salsoline has been researched along with Disease Exacerbation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, T; Maruyama, W; Naoi, M; Tohgi, H | 1 |
1 other study(ies) available for salsoline and Disease Exacerbation
Article | Year |
---|---|
An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Biomarkers; Disease Progression; Dopamine Agents; Female; Humans; Male; Middle Aged; Neurotoxins; Parkinson Disease; Salsoline Alkaloids; Tetrahydroisoquinolines | 1999 |